FineHeart strengthens its Board of Directors with the appointment of Pierre Chauvineau
Bordeaux, France – June 2nd, 2026 – FineHeart, a French clinical-stage medtech company developing FlowMaker®, a breakthrough therapy for the treatment of advanced heart failure, announces the appointment of Pierre Chauvineau as a member of its Board of Directors.